Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Tumour growth and immune evasion as targets for a new strategy in advanced cancer

Nicolini A, Ferrari P, Rossi G, Carpi A.

Endocr Relat Cancer. 2018 Nov 1;25(11):R577–R604. doi: 10.1530/ERC-18-0142.

PMID:
30306784
2.

Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management.

Nicolini A, Ferrari P, Diodati L, Carpi A.

Int J Mol Sci. 2018 Sep 12;19(9). pii: E2733. doi: 10.3390/ijms19092733. Review.

3.

The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy.

Ferreira CG, Nicolini A, Dalurzo L, Stefani S, Teich V, Leighl N.

Curr Drug Targets. 2019;20(1):81-86. doi: 10.2174/1389450119666180911093143.

PMID:
30207218
4.

Evaluation of the odor impact of some environmental gaseous pollutants: calibration of the methodology and preliminary results.

Coccia V, Manni M, Petrozzi A, Nicolini A.

Environ Sci Pollut Res Int. 2018 Oct;25(29):29295-29303. doi: 10.1007/s11356-018-2931-0. Epub 2018 Aug 18.

PMID:
30121760
5.

Tumour growth and immune evasion as targets for a new strategy in advanced cancer.

Nicolini A, Ferrari P, Rossi G, Carpi A.

Endocr Relat Cancer. 2018 Jul 4. pii: ERC-18-0142. doi: 10.1530/ERC-18-0142. [Epub ahead of print]

PMID:
29973339
6.

Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines.

Aghapour F, Moghadamnia AA, Nicolini A, Kani SNM, Barari L, Morakabati P, Rezazadeh L, Kazemi S.

Biochem Biophys Res Commun. 2018 Jun 12;500(4):860-865. doi: 10.1016/j.bbrc.2018.04.174. Epub 2018 Apr 26.

PMID:
29698680
7.

Use of immunotherapy to treat metastatic breast cancer.

Nicolini A, Barak V, Biava P, Ferrari P, Rossi G, Carpi A.

Curr Med Chem. 2018 Feb 9. doi: 10.2174/0929867325666180209124052. [Epub ahead of print]

PMID:
29424297
8.

Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer.

Nicolini A, Ferrari P, Diodati L, Carpi A.

Int J Mol Sci. 2017 Nov 3;18(11). pii: E2321. doi: 10.3390/ijms18112321. Review.

9.

Carbon and energy footprint of the hydrate-based biogas upgrading process integrated with CO2 valorization.

Castellani B, Rinaldi S, Bonamente E, Nicolini A, Rossi F, Cotana F.

Sci Total Environ. 2018 Feb 15;615:404-411. doi: 10.1016/j.scitotenv.2017.09.254. Epub 2017 Oct 5.

PMID:
28988076
10.

Prognostic and predictive biomarkers in breast cancer: Past, present and future.

Nicolini A, Ferrari P, Duffy MJ.

Semin Cancer Biol. 2018 Oct;52(Pt 1):56-73. doi: 10.1016/j.semcancer.2017.08.010. Epub 2017 Sep 4. Review.

PMID:
28882552
11.

Energy from poultry waste: An Aspen Plus-based approach to the thermo-chemical processes.

Cavalaglio G, Coccia V, Cotana F, Gelosia M, Nicolini A, Petrozzi A.

Waste Manag. 2018 Mar;73:496-503. doi: 10.1016/j.wasman.2017.05.037. Epub 2017 May 31.

PMID:
28579143
12.

Biomarkers and the 'target therapies' in oncology, research and business.

Nicolini A.

Biomark Med. 2017 Mar;11(3):217-219. doi: 10.2217/bmm-2016-0216. Epub 2017 Feb 24. No abstract available.

PMID:
28240099
13.

Editorial (Thematic Issue: The Biological Approach to Advanced Cancer: Are We in the Middle of the Road?).

Nicolini A.

Curr Drug Targets. 2016;17(10):1102. No abstract available.

PMID:
27466051
14.

Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update.

Nicolini A, Carpi A, Ferrari P, Biava PM, Rossi G.

Curr Drug Targets. 2016;17(10):1127-39. Review.

PMID:
26844558
15.

Mucins and Cytokeratins as Serum Tumor Markers in Breast Cancer.

Nicolini A, Ferrari P, Rossi G.

Adv Exp Med Biol. 2015;867:197-225. doi: 10.1007/978-94-017-7215-0_13. Review.

PMID:
26530368
16.

Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy.

Sell S, Nicolini A, Ferrari P, Biava PM.

Curr Drug Targets. 2016;17(10):1103-10. Review.

PMID:
26343109
17.

The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer.

Nicolini A, Ferrari P, Kotlarova L, Rossi G, Biava PM.

Curr Pharm Biotechnol. 2015;16(9):804-15. Review.

PMID:
26201609
18.

An individual reference limit for 'early' diagnosis of metastatic breast cancer during postoperative follow-up.

Nicolini A, Ferrari P, Fulceri F, Carpi A, Rossi G.

Biomark Med. 2015;9(4):307-17. doi: 10.2217/bmm.15.6.

PMID:
25808435
19.

Biomarkers: a framework driving advances in oncology.

Nicolini A.

Biomark Med. 2015;9(4):303-6. doi: 10.2217/bmm.15.7. No abstract available.

PMID:
25808434
20.

Effect of double-step steam explosion pretreatment in bioethanol production from softwood.

Cotana F, Cavalaglio G, Gelosia M, Coccia V, Petrozzi A, Nicolini A.

Appl Biochem Biotechnol. 2014 Sep;174(1):156-67. doi: 10.1007/s12010-014-1046-4. Epub 2014 Jul 17.

PMID:
25030294

Supplemental Content

Loading ...
Support Center